| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_183b4416deb995e6af20a56ed5bfaebf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 |
| filingDate |
2001-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ebd1aedf60421dd15a5376a73ad783e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b00d037964705725c85ea36e4c70899 |
| publicationDate |
2003-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-10142881-A1 |
| titleOfInvention |
Combretastatin A-4 (CA4) implants |
| abstract |
The invention relates to implants, in particular intracavernous or intravascular, preferably for the treatment or prophylaxis of coronary or peripheral vascular occlusions or constrictions or stenoses, in particular for the prophylaxis of restenosis, which contain CA4 or CA4P in chemically covalently or non-covalently bound or physically fixed form. Process for their production and their use. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1319978-C |
| priorityDate |
2001-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |